BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 18, 2026
Breaking News: Bundibugyo is harsh reminder of need for broad vaccine strategiesBreaking News: Bundibugyo is harsh reminder of need for broad vaccine strategiesBreaking News: Bundibugyo is harsh reminder of need for broad vaccine strategies
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

Cancer

Shouyao Holdings divulges new DNA-PK inhibitors for cancer

April 6, 2023
Shouyao Holdings (Beijing) Co. Ltd. has synthesized DNA-dependent protein kinase (DNA-PK) inhibitors reported to be useful for the treatment of cancer.
Read More
Cancer

Arvinas Operations patents new PROTACs targeting ER, BRD4, AR and BRAF

April 6, 2023
Arvinas Operations Inc. has disclosed proteolysis...
Read More
Biomarkers

Tyrosine-protein kinase Lyn behind liver fibrosis and cutaneous vasculitis

April 6, 2023
Investigators from the National Institute of Allergy and Infectious Diseases have reported data on a series of 3 patients with perinatal-onset of neutrophilic cutaneous small vessel vasculitis and systemic inflammation, with 2 of them developing liver fibrosis in the first year of their lives.
Read More
COVID-19 research illustration
Infection

Analysis of pre-infection markers and plasma proteins after COVID-19 in people living with HIV

April 6, 2023
Although COVID-19 may be more severe in people with HIV (PWH), the underlying biological mechanisms among PWH treated with antiretroviral therapy (ART) remain largely unknown.
Read More
Kidneys
Nephrology

IMG-025 ameliorates IgA nephropathy by inhibiting lectin-driven complement activation

April 6, 2023
Immunoglobulin A (IgA) nephropathy is the most prevalent glomerulonephritis worldwide that does not have a specific treatment. Its pathogenesis is complex and not well understood, but there is increasing evidence that the lectin-driven complement activation may be behind it. Mannose-binding lectin serine protease 2 (MASP-2) has been studied as a therapeutic target in the treatment of IgA nephropathy, as it is one of the main lectin pathway activators.
Read More
Infection

Grand Pharmaceutical’s APAD cleared to enter clinic in China for sepsis

April 6, 2023
Grand Pharmaceutical Group Ltd. has received...
Read More
Cross section of brain
Neurology/Psychiatric

CVN-417, a nicotinic α6 receptor antagonist for Parkinson’s disease motor dysfunction disclosed

April 6, 2023
Parkinson’s disease (PD) is a neurodegenerative...
Read More
Neurology/Psychiatric

Respirerx collaborates with UCL to study Ampakines for GRIA disorders

April 6, 2023
Respirerx Pharmaceuticals Inc. has entered into...
Read More
Ear and sound waves illustration
Ear, Nose and Throat

Sensorion selects candidate in GJB2-related hearing loss program

April 6, 2023
Sensorion SA has selected a candidate in its...
Read More
Lungs
Respiratory

Boehringer Ingelheim discloses discovery and structure of PDE4 inhibitor BI-1015550

April 6, 2023
Boehringer Ingelheim Pharma GmbH & Co...
Read More
Previous 1 2 … 1126 1127 1128 1129 1130 1131 1132 1133 1134 … 18071 18072 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 18, 2026.
  • DNA and genome editing illustration

    ASGCT 2026: Directed evolution in gene therapy

    BioWorld
    Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Doctor with brain illustration, businessman with dollar sign illustration

    Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal

    BioWorld
    Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
  • Illustration of tau accumulating in a neuron cell.

    Biogen AD drug shows tau, cognition benefit, despite trial miss

    BioWorld
    Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing